Edgewise Therapeutics
(NASDAQ) EWTX
Edgewise Therapeutics Financials at a Glance
Market Cap
$4.40B
Revenue (TTM)
$0.00
Net Income (TTM)
-$176.01M
EPS (TTM)
-$1.66
P/E Ratio
-24.64
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$40.70
Volume
968,030.002
Open
$40.97
Price
$40.70
Volume
968,030.002
Open
$40.97
Previous Close
$40.63
Daily Range
$40.48 - $42.02
52-Week Range
$12.30 - $43.93
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$40.70
Volume
968,030.002
Open
$40.97
Previous Close
$40.63
Daily Range
$40.48 - $42.02
52-Week Range
$12.30 - $43.93
Estimated Earnings Date
Aug 6, 2026
EWTX News
EWTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Edgewise Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
146
CEO
Kevin Koch, PhD
Website
www.edgewisetx.comHeadquarters
Boulder, CO 80303, US
EWTX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-32.55%
Return on Capital
-36.37%
Return on Assets
-33.94%
Earnings Yield
-4.06%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.40B
Shares Outstanding
107.59M
Volume
968.03K
Avg. Volume
1.40M
Financials (TTM)
Gross Profit
-$590.00K
Operating Income
-$199.56M
EBITDA
-$175.97M
Operating Cash Flow
-$148.49M
Capital Expenditure
-$216.00K
Free Cash Flow
-$148.71M
Cash & ST Invst.
$499.56M
Total Debt
$3.79M
Edgewise Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$590.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.40B
N/A
Market Cap/Employee
$37.63M
N/A
Employees
117
N/A
Net Income
-$49.01M
-20.1%
EBITDA
-$48.42M
-20.3%
Quarterly Fundamentals
Total Cash
$499.56M
+14.5%
Total Debt
$3.79M
-16.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.78M
-22.0%
Short Term Debt
$1.02M
+1.6%
Return on Assets
-33.94%
N/A
Return on Invested Capital
-40.24%
N/A
Free Cash Flow
-$42.80M
-12.9%
Operating Cash Flow
-$42.54M
-12.4%